Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: childrens  medical  center  dallas  strokes  pediatric  research  multivu  48624  st  jude  childrens  research  hospital  genome  study  aml  cancer  sequencing  project  aggressive  leukemia  pcgp  multivu  46768  baby  sick  child  donation  comedy  baby  sick  need  donations  childhood  leukemia  saint  jude  children  research  hospital  gene  sequencing  pediatric  cancer  health  multivu  58586  leukemia  cancer  childrens  hospital  philadelphia  chop  cell  therapy  immunotherapy  treatment  research  multivu  64394  penn  medicine  cancer  research  study  immune  cells  leukemia  patients  cellular  therapy  health  multivu  64691  chop  childhood  cancer  advanced  leukemia  relapsed  patients  cell  therapy  treatment  research  multivu  50777  cancer  northwestern  mutual  rose  parade  honda  children  childhood  disease  leukemia  multivu  7422154  leukemia  lymphoma  pbs  cancer  research  treatment  barak  goodman  ken  burns  documentary  film  multivu  7409151  novartis  ctl019  clinical  data  pediatric  children  young  adults  leukemia  refractory  acute  lymphoblastic  multivu  7393851  leukemia  lymphoma  society  health  medical  therapy  research  cancer  treatments  disease  multivu  7554852 
Search // leukemia
Results 1-12 of 24 for ' leukemia ' (0 seconds)
Children’s Medical Center Dallas (Children’s) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children. Pediatric strokes is a little-known condition that occurs as often as leukemia and brain tumors but often is not recognized by parents or physicians, despite the serious short- and long-term health consequences. As part of this effort, Children’s will be one of four research sites in North America participating in this groundbreaking research. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/childrens/48624/
Categories // News and Politics 
Added: 4788 days ago by MultiVuVideo
Runtime: 5m4s | Views: 9397 | Comments: 0
Not yet rated
 

 

 

Researchers have discovered that a subtype of leukemia characterized by a poor prognosis is fueled by mutations in pathways distinctly different from a seemingly similar leukemia associated with a much better outcome. The findings from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project (PCGP) highlight a possible new strategy for treating patients with this more aggressive cancer. The work provides the first details of the genetic alterations fueling a subtype of acute lymphoblastic leukemia (ALL) known as early T-cell precursor ALL (ETP-ALL). The results suggest ETP-ALL has more in common with acute myeloid leukemia (AML) than with other subtypes of ALL. The study appears in the January 12 edition of the journal Nature. To view Multimedia News Release, go to http://www.multivu.com/mnr/46768-st-jude-cancer-genome-sequencing-project-combat-aggressive-leukemia
Categories // Science and Technology 
Added: 4452 days ago by MultiVuVideos
Runtime: 3m59s | Views: 4333 | Comments: 0
Not yet rated
 

 

 

I don't know what to do. Or how to post or where to post this. My son is really sick with leukemia. I can't pay the doctors anymore I need help. If you can donate please go to this site please. http://www.gofundme.com/save-my-baby-boy
Tags // baby  sick  child  donation  comedy 
Categories // Funny  Comedy  Family 
Added: 4250 days ago by tommiza31
Runtime: 1m20s | Views: 2731 | Comments: 1
     
 

 

 

I don\'t know what to do. Or how to post or where to post this. My son is really sick with leukemia. I can\'t pay the doctors anymore I need help. If you can donate please go to this site please. http://www.gofundme.com/save-my-baby-boy
Tags // baby  sick  need  donations 
Categories // Funny  Comedy  Family 
Added: 4255 days ago by tommiza31
Runtime: 1m20s | Views: 2545 | Comments: 1
     
 

 

 

Research led by the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project has identified a fusion gene responsible for almost 30 percent of a rare subtype of childhood leukemia with an extremely poor prognosis. The finding offers the first evidence of a mistake that gives rise to a significant percentage of acute megakaryoblastic leukemia (AMKL) cases in children. AMKL accounts for about 10 percent of pediatric acute myeloid leukemia (AML). The discovery paves the way for desperately needed treatment advances. To view Multimedia News Release, go to http://www.multivu.com/mnr/58586-st-jude-children-s-research-hospital-gene-sequencing-childhood-leukemia
Added: 4152 days ago by MultiVuVideos
Runtime: 3m4s | Views: 2197 | Comments: 1
Not yet rated
 

 

 

Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia (ALL) showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients (89%) experienced complete responses within 28 days after treatment. In all, 27 patients received the treatment--22 children treated at The Children’s Hospital of Philadelphia and five adults treated at the Hospital of the University of Pennsylvania. To view the Multimedia News Release, go to http://www.multivu.com/mnr/64394-chop-penn-harness-engineered-t-cells-eliminate-tumors-in-blood-leukemia
Added: 3762 days ago by MultiVuVideos
Runtime: 8m31s | Views: 1450 | Comments: 1
Not yet rated
 

 

 

Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans. To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Added: 3761 days ago by MultiVuVideos
Runtime: 6m52s | Views: 1364 | Comments: 1
Not yet rated
 

 

 

By reprogramming a 7–year–old girl’s own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed after conventional treatment. The innovative experimental therapy used bioengineered T cells, custom–designed to multiply rapidly in the patient, and then destroy leukemia cells. After the treatment, the child’s doctors found that she had no evidence of cancer. To view Multimedia News Release, go to http://www.multivu.com/mnr/50777-chop-engineered-immune-t-cell-therapy-anticancer-effect-in-children
Added: 4126 days ago by MultiVuVideos
Runtime: 6m45s | Views: 1338 | Comments: 0
     
 

 

 

Northwestern Mutual, presenting sponsor of the Rose Bowl Game, today announced that its float in the 127th Rose Parade presented by Honda in Pasadena on Jan. 1, 2016, will support the fight against childhood cancer. The theme of this year’s parade is Find Your Adventure. Northwestern Mutual will dedicate its float design to the greatest adventure and dream of 13-year-old Peyton Richardson of Sugar Land, Texas, who is in treatment for acute lymphocytic leukemia (ALL). Northwestern Mutual is committed to raising awareness, accelerating the search for cures to childhood cancer and providing support to families battling the disease. Peyton, an aspiring ballerina, would like to see the performances of the distinguished ballet companies of the world and have a ballet lesson with one of their principal dancers. Peyton’s adventure will be brought to life in flowers by Fiesta Parade Floats. To view the multimedia release go to: http://www.multivu.com/players/English/7422154-northwestern-mutual-rose-bowl/
Categories // Miscellaneous 
Added: 3122 days ago by MultiVuVideos
Runtime: 1m32s | Views: 838 | Comments: 0
Not yet rated
 

 

 

Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer. LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures. To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
Added: 3321 days ago by MultiVuVideos
Runtime: 1m5s | Views: 831 | Comments: 2
Not yet rated
 

 

 

Findings from continued clinical studies of investigational chimeric antigen receptor (CAR) therapy, CTL019, demonstrate its potential role in the treatment of certain types of lymphocytic leukemia. In one long-term study of pediatric patients with acute lymphoblastic leukemia (ALL), results showed that 36 of 39 pediatric patients with relapsed/refractory (r/r) ALL, or 92%, experienced complete remissions (CR) with CTL0191. To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7393851-novartis-new-ctl019-clinic-data-acute-lymphoblastic-leukemia/
Categories // Miscellaneous 
Added: 3396 days ago by MultiVuVideos
Runtime: 1m8s | Views: 782 | Comments: 0
Not yet rated
 

 

 

The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers. Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep. To view the multimedia release go to: http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Categories // Miscellaneous 
Added: 3102 days ago by MultiVuVideos
Runtime: 1m4s | Views: 762 | Comments: 0
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.